Navigation Links
Investor Uprising Publishes Free Biotech Investment Report
Date:6/1/2011

NEW YORK, June 1, 2011 /PRNewswire/ -- Investor Uprising (www.investoruprising.com) has released "A Guide to Biotech Investing," a four-page, definitive guide to the best biotech Exchange Traded Funds (ETFs) and mutual funds, which is available free to registered users of the Website.

(Logo: http://photos.prnewswire.com/prnh/20110411/NY80781LOGO-a)

"A Guide to Biotech Investing" analyzes the ongoing biotech bull market, identifying the leading biotech mutual funds and ETFs. It explains how individual investors can gain exposure to the biotech market to diversify their portfolios, as well as how to go about looking at a variety of biotech funds and ETFs.

"Biotech has been roaring forward, and not a lot of investors are aware of how to gain exposure to the market," says R. Scott Raynovich, editor-in-chief, Investor Uprising. "Biotech ETFs are a good play in an appealing investment sector with relatively low correlation to macro-economic problems."

Some biotech funds identified in the report are up more than 100% over the last five years, with less volatility than the Nasdaq Index. This report tells you why, and how to tell the funds apart. The report explains the components of the various biotech ETFs and which should be sought for either large-cap or mid-cap investments. The report compares the leading biotech funds and ETFs with leading technology ETFs.

The mutual funds and ETFs tracked by the report include the T. Rowe Price Health Sciences Fund (PRHSX), Fidelity Select Biotechnology fund (FBIOX), BlackRock Health Sciences Ops Inv A (SHSAX), Vanguard Healthcare ETF (VHT), First Trust NYSE Arca Biotech Index (NYSE: FBT), iShares Nasdaq Biotechnology Index (Nasdaq: IBB), and the SPDR S&P Biotech ETF (NYSE: XBI).

The report is the second in a series of free ground-breaking reports published on Investor Uprising and available to registered readers for free. Readers can register for the site here.

About Investor Uprising

Investor Uprising is the individual investor's no-nonsense community for accessing business trends and investment strategies. Combining expert market commentary, fundamental analysis and on-the-ground reporting, Investor Uprising helps the reader find the best investment opportunities in global markets. Sponsored by PR Newswire and operated by UBM plc, Investor Uprising's community of contributors will reach millions of potential business readers around the world.

About PR Newswire

PR Newswire (www.prnewswire.com) is the premier global provider of multimedia platforms that enable marketers, corporate communicators, sustainability officers, and public affairs and investor relations officers to leverage content to engage with all their key audiences. Having pioneered the commercial news distribution industry 56 years ago, PR Newswire today provides end-to-end solutions to produce, optimize, and target content – from rich media to online video to multimedia – and then distribute content and measure results across traditional, digital, mobile, and social channels. Combining the world's largest multi-channel, multi-cultural content distribution and optimization network with comprehensive workflow tools and platforms, PR Newswire enables the world's enterprises to engage opportunity everywhere it exists. PR Newswire serves tens of thousands of clients from offices in the Americas, Europe, Middle East, Africa, and the Asia-Pacific region, and is a UBM plc company.

About DeusM

DeusM (www.deusm.com) is headquartered in New York City. Its name is an abbreviation of Deus Ex Machina, a term derived from classical drama that describes the moment that a god is introduced into a play to resolve the entanglements of the plot. The company specializes in the use of proprietary high-value content and Web 2.0 technology to attract highly qualified audiences to its communities – and keep them engaged there.  DeusM is a UBM plc company.

Media Contact:
Rachel Meranus
Vice President, Marketing and Communications
PR Newswire
+1.201.360.6776
Rachel.Meranus@prnewswire.com

Meryl Serouya
Marketing & Communications Associate
PR Newswire
+1.201.360-6009
Meryl.Serouya@prnewswire.com


'/>"/>
SOURCE Investor Uprising
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Ardea Biosciences to Present at Upcoming Investor Conferences
2. Caliper Owners Group and Investor Meeting to Highlight Technologies Enabling Personalized Medicine
3. Sangamo BioSciences Announces Presentation at Two Upcoming Investor Conferences
4. VIVUS to Present at Four Upcoming Investor Conferences in May
5. Life Technologies to Webcast Investor Presentation as Part of the Morgan Stanley West Coast Medtech and Life Science Tools Bus Trip
6. Gen-Probe to Webcast Two Upcoming Investor Presentations
7. Chimerix to Present at Two Upcoming Investor Conferences
8. NOVAVAX Announces Release Date of 2010 Year-End Financial Results and Investor Conference Call
9. Healthzone Limited Engages The Trout Group for Investor Relations Services
10. Life Technologies to Webcast Investor Presentation as Part of the UBS West Coast Life Sciences & Diagnostics Bus Trip
11. Aethlon Medical to Present at the Wall Street Analyst Forum 22nd Annual Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... ... ... Scientists at the University of Athens say they have evidence that the ... research that could lead to one good one. Surviving Mesothelioma has just posted an ... The team evaluated 98 mesothelioma patients who got a second kind of ...
(Date:5/24/2016)... May 24, 2016   MedyMatch Technology Ltd ., the ... intelligence, real-time decision support tools in the emergency room, announced ... 2016 Israeli Advanced Technology Industries (IATI) BioMed Conference. ... 15th National Life Sciences and Technology Week, and ... Intercontinental Hotel in Tel Aviv, Israel . ...
(Date:5/23/2016)... Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), ... Board of Directors has approved the payment of a quarterly ... The cash dividend of $0.24 per share ... stockholders of record as of the close of business on ... approval of the Board of Directors and may be adjusted ...
(Date:5/22/2016)... ... May 22, 2016 , ... Doctors in Rome say micronutrients ... asbestos cancer, malignant mesothelioma. Surviving Mesothelioma has just posted an article on the new ... of Rome’s Department of Clinical Sciences and Translational Medicine evaluated more than 150 studies ...
Breaking Biology Technology:
(Date:3/9/2016)... PALM BEACH GARDENS, Fla. , March 9, ... of identity management authentication and enrollment solutions, today ... proven DigitalPersona ® Altus multi-factor ... enable IT and InfoSec managers to step-up security ... friction.  Washington, DC ...
(Date:3/3/2016)... , March 3, 2016  FlexTech, a SEMI ... categories of Innovation, Research & Development, Leadership in Education, ... This is the 9 th year of the ... of companies and individuals from past years . ... on a pre-described set of criteria, by a panel ...
(Date:3/3/2016)... DE SOTO, Kansas , March 3, ... Plus® to offer Oncimmune,s Early CDT®-Lung, a blood ... detection of lung cancer Early CDT®-Lung test ... individuals. --> Early CDT®-Lung test to its ... --> Oncimmune, a leader in early cancer detection, ...
Breaking Biology News(10 mins):